Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02508532
Title Phase 1 Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Blueprint Medicines Corporation
Indications

gastrointestinal stromal tumor

Advanced Solid Tumor

Therapies

Avapritinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.